These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9512685

  • 41. [An anaphylactic shock case after hepatic arterial infusion of zinostatin stimalamer suspension improved by anti-histaminics].
    Fukuhara K, Suzuki M, Unno M, Rikiyama T, Sakamoto N, Takeuchi H, Uchiyama T, Yamaki T, Iwasashi H, Kodama H, Matsuno S.
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):1023-6. PubMed ID: 9212813
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H.
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
    [Abstract] [Full Text] [Related]

  • 47. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K, Saitoh S, Kumada H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [Abstract] [Full Text] [Related]

  • 48. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].
    Umeda S, Ito K, Takahashi E, Kimura F, Sumitomo M, Kaji T, Hayakawa M, Asano T.
    Hinyokika Kiyo; 2010 Oct; 56(10):543-9. PubMed ID: 21063157
    [Abstract] [Full Text] [Related]

  • 52. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
    Suzuki T, Kobayashi M, Nakamura T, Takahashi O, Imai K, Yamanaka H, Suzuki K, Konno T, Maeda H.
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct 20; 22(9):2210-7. PubMed ID: 2833546
    [No Abstract] [Full Text] [Related]

  • 53. [SMANCS/lipiodol].
    Maeda H.
    Gan To Kagaku Ryoho; 1994 May 20; 21(6):907-13. PubMed ID: 8185354
    [Abstract] [Full Text] [Related]

  • 54. Chemoembolization for hepatocellular carcinoma.
    Nakamura H.
    Gan To Kagaku Ryoho; 1996 Sep 20; 23(11):1390-1. PubMed ID: 8854761
    [No Abstract] [Full Text] [Related]

  • 55. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Ogura T, Hagihara A, Iwasa S.
    Cancer Chemother Pharmacol; 2008 Apr 20; 61(4):683-8. PubMed ID: 17541589
    [Abstract] [Full Text] [Related]

  • 56. [Case of gastric perforation after TAI (trancatheter arterial infusion) of SMANCS with special reference to accessory left gastric artery].
    Takeuchi N, Shioyama Y.
    Gan To Kagaku Ryoho; 2005 Apr 20; 32(4):547-51. PubMed ID: 15853226
    [Abstract] [Full Text] [Related]

  • 57. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug 20; 18(10):1665-75. PubMed ID: 1714707
    [Abstract] [Full Text] [Related]

  • 58. Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.
    Yumoto Y, Jinno K, Tokuyama K, Wada T, Kobashi H, Okamoto T, Toki H, Inatsuki S, Hara K, Moriwaki S.
    Int J Hyperthermia; 1991 Aug 20; 7(1):7-17. PubMed ID: 1711090
    [Abstract] [Full Text] [Related]

  • 59. [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors].
    Konno T, Iwai K, Maki S, Tashiro S, Miyauchi Y, Maeda H, Yokoyama I.
    Nihon Geka Gakkai Zasshi; 1984 Sep 20; 85(9):1151-6. PubMed ID: 6095018
    [Abstract] [Full Text] [Related]

  • 60. [The effect of hepatic arterial infusion chemotherapy on the prognosis after hepatectomy for hepatocellular carcinoma].
    Takagi K, Koyama T, Hasegawa M, Manabe K.
    Gan To Kagaku Ryoho; 1998 Mar 20; 25(4):597-600. PubMed ID: 9530370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.